Canntab Therapeutics Limited (CTABF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 293.36 Thousand | - | 133.33 Thousand | 239.99 Thousand | 26.66 Thousand | - |
| Cost of Revenue | 1.23 Million | 546.34 Thousand | - | 96.38 Thousand | - | - |
| Gross Profit | -939.01 Thousand | -546.34 Thousand | 133.33 Thousand | 143.61 Thousand | 26.66 Thousand | - |
| Operating Expenses | 3.22 Million | 3.33 Million | 2.74 Million | 2.74 Million | 2.45 Million | 1.11 Million |
| Selling, General and Administrative Expenses | 2.82 Million | 2.7 Million | 2.33 Million | 2.43 Million | 2.25 Million | 1.07 Million |
| Research and Development Expenses | 205.03 Thousand | 80.35 Thousand | 105.74 Thousand | 128.14 Thousand | 140.73 Thousand | 40.68 Thousand |
| Other Expenses | 192.91 Thousand | -429.98 Thousand | - | - | - | - |
| Cost and Expenses | 4.45 Million | 3.33 Million | 2.74 Million | 2.74 Million | 2.45 Million | 1.11 Million |
| Operating Income | -4.16 Million | -3.78 Million | -2.61 Million | -2.5 Million | -2.42 Million | -1.11 Million |
| Interest Expense | 566.67 Thousand | 188.72 Thousand | 26.58 Thousand | - | - | - |
| Income Tax Expense | - | 188.72 Thousand | 89.31 Thousand | -91.25 Thousand | - | -50.9 Thousand |
| Earnings before Tax | -3.68 Million | -4.41 Million | -2.6 Million | -2.45 Million | -2.4 Million | -1.11 Million |
| Net Income | -3.68 Million | -4.41 Million | -2.6 Million | -2.45 Million | -2.4 Million | -1.11 Million |
| Earnings Per Share Basic | -0.10 | -0.13 | -0.10 | -0.10 | -0.11 | -0.07 |
| Earnings Per Share Diluted | -0.10 | -0.13 | -0.10 | -0.10 | -0.11 | -0.07 |
| Weighted Average Shares Outstanding | 37.72 Million | 34.55 Million | 27.16 Million | 25.29 Million | 21.12 Million | 15 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.72 Million | 34.55 Million | 27.16 Million | 25.29 Million | 21.12 Million | 15 Million |
| Gross Margin | -3.20 | - | 1.00 | 0.60 | 1.00 | - |
| EBIT Margin | -10.10 | - | -17.40 | -10.09 | -88.95 | - |
| Profit Margin | -12.58 | - | -19.55 | -10.24 | -90.31 | - |
| EBITDA | -2.96 Million | -3.13 Million | -2.32 Million | -2.42 Million | -2.37 Million | -1.11 Million |
| Earnings Before Tax Margin | -14.19 | - | -19.62 | -10.42 | -90.88 | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | -22.15 Thousand | 17.58 Thousand | 38.5 Thousand | 39.54 Thousand | 293.36 Thousand | 48.46 Thousand |
| Cost of Revenue | -17.24 Thousand | 17.16 Thousand | 12.01 Thousand | 93.87 Thousand | 223.89 Thousand | 25.37 Thousand |
| Gross Profit | -4910.00 | 421.00 | 26.48 Thousand | -54.33 Thousand | 69.46 Thousand | 23.08 Thousand |
| Operating Expenses | 519.73 Thousand | 499.38 Thousand | 573.85 Thousand | 896.4 Thousand | 3.66 Million | 825.53 Thousand |
| Selling, General and Administrative Expenses | 87.32 Thousand | 309.46 Thousand | 421.79 Thousand | 648.07 Thousand | - | 635.32 Thousand |
| Research and Development Expenses | 540.00 | 18.2 Thousand | 13.05 Thousand | 59.75 Thousand | - | 81.12 Thousand |
| Other Expenses | 431.87 Thousand | -75 Thousand | - | -1 Million | -1 Million | - |
| Cost and Expenses | 502.48 Thousand | 516.55 Thousand | 585.87 Thousand | 990.28 Thousand | 3.89 Million | 850.9 Thousand |
| Operating Income | -345.8 Thousand | -738.97 Thousand | -761.35 Thousand | -1.16 Million | -4.16 Million | -909.37 Thousand |
| Interest Expense | 161.52 Thousand | 240 Thousand | 213.98 Thousand | 210.77 Thousand | 566.67 Thousand | 106.92 Thousand |
| Income Tax Expense | 161.52 Thousand | 240 Thousand | 213.98 Thousand | 210.77 Thousand | 566.67 Thousand | 106.92 Thousand |
| Earnings before Tax | -412.62 Thousand | -1.03 Million | -467.8 Thousand | -1.44 Million | -3.68 Million | -418.33 Thousand |
| Net Income | -412.62 Thousand | -1.03 Million | -467.8 Thousand | -1.44 Million | -3.68 Million | -418.33 Thousand |
| Earnings Per Share Basic | -0.01 | -0.03 | -0.01 | -0.04 | - | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.03 | -0.01 | -0.04 | - | -0.01 |
| Weighted Average Shares Outstanding | 38.9 Million | 38.9 Million | 38.9 Million | 38.9 Million | 37.72 Million | 37.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.9 Million | 38.9 Million | 38.9 Million | 38.9 Million | 37.72 Million | 37.73 Million |
| Gross Margin | 0.22 | 0.02 | 0.69 | -1.37 | 0.24 | 0.48 |
| EBIT Margin | 19.55 | -18.61 | -10.61 | -19.34 | - | -14.26 |
| Profit Margin | 18.62 | -58.61 | -12.15 | -36.53 | -12.58 | -8.63 |
| EBITDA | -433.13 Thousand | -327.24 Thousand | -408.36 Thousand | -764.6 Thousand | - | -690.93 Thousand |
| Earnings Before Tax Margin | 15.61 | -42.02 | -19.77 | -29.38 | -14.19 | -18.77 |
GCOM
LTRYW
STP
LTFD
PRSI
AQQSQ